SCHEMBL15947643

SCHEMBL15947643

Cc1ccc(C#Cc2nccc3ccccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.49
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C19 P33261 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP1 P29466 1/20 0.43
RAB9A P51151 1/20 0.43
CASP7 P55210 1/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ADORA2A P29274 1/20 0.41
F12 P00748 1/20 0.41
PLAU P00749 1/20 0.41
NCF1 P14598 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15940603 0.86 ADORA2A (0.54) CYP2A6CYP3A4CYP2C19KDM4ENPC1
Hydrochloric Acid SCHEMBL8116929 0.85 ADORA2A (0.53) CYP2A6CYP3A4CYP2C19KDM4ENPC1
SCHEMBL15947640 0.84 PLAU (0.54) CYP2A6CYP3A4CYP2C19KDM4ENPC1
SCHEMBL12324740 0.84 PLAU (0.49) CYP2A6CYP1A2NPC1ALDH1A1MAPT
SCHEMBL15947630 0.83 APP (0.44) CYP2A6RAB9AATMADORA2AKCNH2
SCHEMBL484167 0.83 S100A4 (0.51) CYP2A6MAPTADK
SCHEMBL15947631 0.80 KDM1A (0.40) CYP2A6NPC1ALDH1A1MAPTMAPK1
SCHEMBL29620166 0.77 GRM5 (0.50) CYP2A6ADORA2AF12PLAUNCF1
SCHEMBL15947632 0.76 HRH4 (0.39) KDM4ENPC1ALDH1A1MAPTHPGD
SCHEMBL2431412 0.75 CYP2A6 (0.48) CYP2A6CYP3A4CYP2C19KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9879004-B2 Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4 MERCK PATENT GMBH (DE) 2018-01-30 US disclosed
US-20150376182-A1 Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 MERCK PATENT GMBH (DE) 2015-12-31 US disclosed
WO-2014121883-A1 SUBSTITUTED ACETYLENE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4 MERCK PATENT GMBH (DE) 2014-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376182-A1 Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 GRM4, GRIA4, GRIK4 CYP2A6 3849/4885CYP1A2 4148/4885CYP3A4 1886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.